Relapse rates and predictors for relapse in a real-life cohort of IBD patients after discontinuation of anti-TNF therapy
Author:
Affiliation:
1. Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
Publisher
Informa UK Limited
Subject
Gastroenterology
Link
https://www.tandfonline.com/doi/pdf/10.1080/00365521.2019.1582693
Reference39 articles.
1. Long-term Infliximab Maintenance Therapy for Ulcerative Colitis: The ACT-1 and -2 Extension Studies
2. Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab
3. Infliximab therapy for patients with inflammatory bowel disease: 10years on
4. Long-term treatment of rectovaginal fistulas in Crohn’s disease: Response to infliximab in the ACCENT II Study
5. Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Potential of Molecular Remission: Tissue Neutrophil Elastase Is Better Than Histological Activity for Predicting Long-Term Relapse in Patients With Ulcerative Colitis in Endoscopic Remission;Inflammatory Bowel Diseases;2024-08-27
2. De-escalating therapy in inflammatory bowel disease: Results from an observational study in clinical practice;Gastroenterología y Hepatología (English Edition);2024-08
3. Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort study;Digestive and Liver Disease;2024-06
4. Estimation of patients affected by inflammatory bowel disease potentially eligible for biological treatment in a real-world setting;Digestive and Liver Disease;2024-01
5. Impact of the COVID-19 Pandemic on the Lifestyle and Psychosocial Behavior of Patients with Inflammatory Bowel Diseases: A Narrative Review;Healthcare;2023-09-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3